DAVID A RAMSAY

CIK 1283292 · Interim CFO · last filed 2026-04-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.33M

Companies

5

Total Filings

76

Lifetime Open-Market Net

$4.25M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HTI Interim CFO 364,320 -$33.8K 19 2026-04-02
SVRA Director 2,533,642 $5.26 $13.33M $3.85M 39 2025-12-19
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Director 97,000 $6.22 $603.3K $384.8K 9 2022-01-14
MSTX Director $16.18 $0 4 2017-01-23
Savara Inc (ANX) Delisted Director 100,000 $55.1K 4 2012-07-30

Recent Filings · Page 2 of 8

76 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-12-22 SVRA Buy (P) +45,000 $66.4K EDGAR
2022-12-20 SVRA Buy (P) +54,890 $82.1K EDGAR
2022-12-15 SVRA Grant (A) $0 EDGAR
2022-11-25 SVRA Buy (P) +20,105 $28.7K EDGAR
2022-11-21 SVRA Buy (P) +50,005 $68.4K EDGAR
2022-09-27 SVRA Buy (P) +135,000 $187.1K EDGAR
2022-09-20 SVRA Buy (P) +8,000 $11.6K EDGAR
2022-09-08 SVRA Buy (P) +32,000 $44.7K EDGAR
2022-09-01 SVRA Buy (P) +100,000 $141.9K EDGAR
2022-08-24 Disp (D) −100,000 -$623.0K
Showing 1120 of 76
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.